Last December, Germany – like many other countries around the world – began a massive campaign of vaccinations against Covid-19. Part of Menarini Group since 1992, BERLIN-CHEMIE wanted to make its own contribution in creating an “assembly line” to get the vaccination off the ground, involving as many employees as possible to take part in […]
Read moreAn important milestone has been reached with the celebration of 25 years of Menarini Switzerland, a young member of our Big Family in the heart of Europe. Established in 1996 in Zurich, A. Menarini GmbH is located in Oerlikon, a lively shopping district just a 7-minute walk from Switzerland’s third busiest railway station. The first […]
Read more2020 has been an unprecedentedly arduous year around the world. Many industrial sectors – including pharmaceuticals and healthcare – have been affected by the pandemic. In such a delicate context, undertaking a $677 million operation by purchasing 100% of the shares of a major US biopharmaceutical company was a bold move, that allowed Menarini Group […]
Read moreMenarini, the largest pharmaceutical company in Italy with affiliates in 140 countries and over 17,000 employees – over 4,000 of which are based in the country – resulted at the top of the rankings drawn up by Universum as «Most attractive employers» in the field of health and medicine. «This is a complex and diversified […]
Read moreMenarini Asia Pacific “jumps” in 2021 alongside the National Kidney Foundation (NKF), running for a good cause: to inspire and support people suffering from kidney failure. The number of new cases has increased about 60% over the past 10 years with diabetes being the number-one-cause of kidney failure. However, more than half who have diabetes […]
Read moreFollowing on from the success of Pills of Art – whose videos have made 18 million views worldwide – Menarini launches a new version dedicated to children and teens. In this new and fresh series, children have a starring role. Precisely the kids are the ones asking the art expert the most disparate questions – […]
Read more